These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 3940287)

  • 1. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
    J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
    Lange KW; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1993 Jan; 60(1):197-203. PubMed ID: 8417140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease.
    Reinikainen KJ; Riekkinen PJ; Halonen T; Laakso M
    Life Sci; 1987 Jul; 41(4):453-61. PubMed ID: 3600187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
    Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
    Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
    Ruberg M; Ploska A; Javoy-Agid F; Agid Y
    Brain Res; 1982 Jan; 232(1):129-39. PubMed ID: 7055689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine administered into the area of the nucleus basalis decreases cortical nicotinic cholinergic receptors labelled by [3H]-acetylcholine.
    Tilson HA; Schwartz RD; Ali SF; McLamb RL
    Neuropharmacology; 1989 Aug; 28(8):855-61. PubMed ID: 2779754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.
    Abood LG; Saraswati M; Lerner-Marmarosh N; Hashmi M
    Biochem Pharmacol; 1993 May; 45(10):2143-8. PubMed ID: 8512596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An autoradiographic analysis of cholinergic receptors in mouse brain.
    Pauly JR; Stitzel JA; Marks MJ; Collins AC
    Brain Res Bull; 1989 Feb; 22(2):453-9. PubMed ID: 2706548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains.
    Nordberg A; Winblad B
    Neurosci Lett; 1986 Dec; 72(1):115-9. PubMed ID: 3808458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topographic distribution of choline acetyltransferase activity and muscarinic and nicotinic receptors in Parkinson brains.
    Nordberg A; Nyberg P; Windblad B
    Neurochem Pathol; 1985; 3(4):223-36. PubMed ID: 3831845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics.
    Hellström-Lindahl E; Winblad B; Nordberg A
    Brain Res; 1993 Aug; 620(1):42-8. PubMed ID: 8402197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex.
    Watson M; Vickroy TW; Fibiger HC; Roeske WR; Yamamura HI
    Brain Res; 1985 Nov; 346(2):387-91. PubMed ID: 3840399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal development of cholinergic enzymes and receptors in mouse brain.
    Fiedler EP; Marks MJ; Collins AC
    J Neurochem; 1987 Sep; 49(3):983-90. PubMed ID: 3612135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of muscarinic and nicotinic binding sites in brain.
    Nordberg A; Larsson C
    Acta Physiol Scand Suppl; 1980; 479():19-23. PubMed ID: 6932800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in binding to muscarinic and nicotinic cholinergic receptors in the chick telencephalon, following passive avoidance learning.
    Mezey S; Székely AD; Bourne RC; Kabai P; Csillag A
    Neurosci Lett; 1999 Jul; 270(2):75-8. PubMed ID: 10462101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of electroconvulsive shock on muscarinic cholinergic receptors in rat cerebral cortex and hippocampus.
    Lerer B; Stanley M; Demetriou S; Gershon S
    J Neurochem; 1983 Dec; 41(6):1680-3. PubMed ID: 6644306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
    Perry EK; Smith CJ; Court JA; Perry RH
    J Neural Transm Park Dis Dement Sect; 1990; 2(3):149-58. PubMed ID: 2175197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic muscarinic and nicotinic binding by human lymphocytes: differences between peripheral blood cells and cultivated cell lines.
    Grabczewska E; Laskowska-Bozek H; Maśliński W; Ryzewski J
    Int J Tissue React; 1990; 12(5):281-9. PubMed ID: 2098370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scopolamine induces up-regulation of nicotinic receptors in intact brain but not in nucleus basalis lesioned rats.
    Vige X; Briley M
    Neurosci Lett; 1988 Jun; 88(3):319-24. PubMed ID: 3386878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.